BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24067333)

  • 1. Dual intervention to improve pathologic staging of resectable lung cancer.
    Osarogiagbon RU; Ramirez RA; Wang CG; Miller LE; Smeltzer MM; Sareen S; Javed AY; Robbins SG; Khandekar A; Wolf BA; Gibson J; Spencer D; Robbins ET
    Ann Thorac Surg; 2013 Dec; 96(6):1975-81. PubMed ID: 24067333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).
    Osarogiagbon RU; Decker PA; Ballman K; Wigle D; Allen MS; Darling GE
    Ann Thorac Surg; 2016 Aug; 102(2):363-9. PubMed ID: 27262908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A standardized technique of systematic mediastinal lymph node dissection by video-assisted thoracoscopic surgery (VATS) leads to a high rate of nodal upstaging in early-stage non-small cell lung cancer.
    Reichert M; Steiner D; Kerber S; Bender J; Pösentrup B; Hecker A; Bodner J
    Surg Endosc; 2016 Mar; 30(3):1119-25. PubMed ID: 26169635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
    Darling GE; Allen MS; Decker PA; Ballman K; Malthaner RA; Inculet RI; Jones DR; McKenna RJ; Landreneau RJ; Rusch VW; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):662-70. PubMed ID: 21335122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.
    Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Levy P; Wiggins L; Sachdev V; Robbins T; Spencer D; Osarogiagbon RU
    Ann Thorac Surg; 2018 Jul; 106(1):228-234. PubMed ID: 29534956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Video-assisted thoracic surgery systematic mediastinal nodal dissection and stage migration: impact on clinical pathway.
    Amer K; Khan AZ; Singh N; Addis B; Jogai S; Harden S; Peebles C; Brown I
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1474-81. PubMed ID: 21497109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer.
    Shapiro M; Kadakia S; Lim J; Breglio A; Wisnivesky JP; Kaufman A; Lee DS; Flores RM
    Chest; 2013 Nov; 144(5):1615-1621. PubMed ID: 23828253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancer.
    Osarogiagbon RU; Miller LE; Ramirez RA; Wang CG; O'Brien TF; Yu X; Khandekar A; Schoettle GP; Robbins SG; Robbins ET; Gibson JB
    J Thorac Oncol; 2012 Aug; 7(8):1276-82. PubMed ID: 22653076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer.
    Merritt RE; Hoang CD; Shrager JB
    Ann Thorac Surg; 2013 Oct; 96(4):1171-1177. PubMed ID: 23915591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.
    Osarogiagbon RU; Ray MA; Fehnel C; Akinbobola O; Saulsberry A; Dortch K; Faris NR; Matthews AT; Smeltzer MP; Spencer D;
    Ann Thorac Surg; 2024 Mar; 117(3):576-584. PubMed ID: 37678613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary comparison research of thoracoscopy and thoracotomy lobectomy for clinical N0 and post-operatively pathological N2 non-small cell lung cancer].
    Li FW; Jiang GC; Li Y; Bu L; Yang F; Li JF; Zhao H; Liu YG; Zhou ZL; Liu J; Wang J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):861-5. PubMed ID: 22178835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients.
    Turna A; Melek H; Kara HV; Kılıç B; Erşen E; Kaynak K
    J Thorac Cardiovasc Surg; 2018 Feb; 155(2):789-795. PubMed ID: 29110950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical feasibility and surgical benefits of video-assisted mediastinoscopic lymphadenectomy in the treatment of resectable lung cancer.
    Yoo DG; Kim YH; Kim DK; Kim HR; Park SI
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1483-6. PubMed ID: 21570859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of nodal upstaging in patients with cT1-3N0 non-small cell lung cancer (NSCLC): results from the Italian VATS Group Registry.
    Marulli G; Faccioli E; Mammana M; Nicotra S; Comacchio G; Verderi E; De Palma A; Rea F;
    Surg Today; 2020 Jul; 50(7):711-718. PubMed ID: 31873770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study.
    Osarogiagbon RU; Smeltzer MP; Faris NR; Ray MA; Fehnel C; Ojeabulu P; Akinbobola O; Meadows-Taylor M; McHugh LM; Halal AM; Levy P; Sachdev V; Talton D; Wiggins L; Shu XO; Shyr Y; Robbins ET; Klesges LM
    J Thorac Oncol; 2021 Apr; 16(4):630-642. PubMed ID: 33607311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.